2 recruiting, 1 withdrawn. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow First Ascent Biomedical Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| xDRIVE for Florida-based Cancer Patients xDRIVE Tumor Profiling - Cancer, Neoplams | Not applicable | Recruiting | First Ascent Biomedical Inc. | 210 | 2025-11-01 | 2026-05-19 |
| xDRIVE in Metastatic Colorectal Cancer Functional precision medicine - Metastatic Colon Adenocarcinoma, Metastatic Colon Cancer | Withdrawn | First Ascent Biomedical Inc. | 2025-09-15 | 2026-09-02 | ||
| Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling Functional Precision Medicine - Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia | Phase 1 | Recruiting | Florida International University | 65 | 2023-02-22 | 2026-08-26 |
Neoplasms (2) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Familial ependymoma (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Lymphoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Rectal Neoplasms (1) · Recurrence (1)
United States (2)
Diana Azzam (1) · Diana J Azzam, PhD (1) · Hao Xie, MD PhD (1) · Lisa Boardman, MD (1) · Maggie Fader (1) · Noah Berlow, PhD (1)
U54MD012393 (1)